Navigation Links
Chimerix Files Registration Statement for Proposed Initial Public Offering
Date:3/8/2013

RESEARCH TRIANGLE PARK, N.C., March 8, 2013 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.  The number of shares to be offered and the price range for the offering have not been determined.

Morgan Stanley and Cowen and Company are acting as joint book-running managers for the offering.  William Blair and Lazard Capital Markets are acting as co-managers.

The offering will be made only by means of a prospectus.  When available, copies of the preliminary prospectus relating to the offering may be obtained from: Morgan Stanley & Co., LLC, Attn: Prospectus Department, 180 Varick Street, New York, New York 10014, or by calling toll free 1-866-718-1649 or emailing at prospectus@morganstanley.com; or Cowen and Company, LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, Attn: Prospectus Department, by calling (631) 274-2806, or faxing (631) 254-7140.

A registration statement relating to these securities has been filed with the SEC, but has not yet become effective.  These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Chimerix and CMX001
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
2. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
3. Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
4. Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV
5. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
6. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
7. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
8. Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2012
9. AUL Files Seventh Brief Supporting First Amendment Freedom of Conscience
10. OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
11. Terumo Medical Corporation Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... March 31, 2015.  The net loss and the loss ... and $13.0 million, respectively, compared to $10.7 million and ...  At March 31, 2015, Alexza had consolidated cash, cash ... "We continue to focus on ways in ...
(Date:5/6/2015)... 2015  Integrative medicine interventions lead to significant ... chronic pain, depression, and stress, according to ... Bravewell Collaborative . The findings are based on ... Interventions Effectiveness Registry (PRIMIER), the first-ever patient registry ... PRIMIER , researchers found that the use ...
(Date:5/6/2015)... CVS Health (NYSE: CVS ) officially announced today ... locations that sustained heavy fire damage during protests last week.  ... over the past week or so, our hearts turned ... Health President and CEO Larry Merlo . "Our purpose as ... There is no better way that we can fulfill that purpose ...
Breaking Medicine Technology:Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10Integrative Medicine has Positive Impact on Patient Activation, Chronic Pain, Depression 2CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2
... Jan. 3, 2011 Bacterin International Holdings, Inc. ... that it is scheduled to present at the upcoming OneMedForumSF ... at 8:30 a.m. (PT) at the Sir Francis Drake Hotel ... of Bacterin will present the Company,s operations and its strategic ...
... SRI International, an independent nonprofit research and development organization, ... Sarnoff Corporation, its wholly owned subsidiary in Princeton, New ... welcome our new colleagues to SRI and celebrate their ... Carlson, Ph.D., president and CEO of SRI International. "Together, ...
Cached Medicine Technology:Bacterin International Holdings to Present at the OneMedForum San Francisco 2011 2Bacterin International Holdings to Present at the OneMedForum San Francisco 2011 3
(Date:5/6/2015)... May 06, 2015 Inversion Studios, ... in yoga and Pilates classes, provides personalized individual ... products, starting with its new Pilates Ring magic ... of becoming leaner, stronger, more centered and graceful, ... a fresh venue to healthy fitness through yoga ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Vancouver ... recently shared their new blog containing the Canadian ... by the Canadian Society for Exercise Physiology (CSEP). ... physical activity, health and fitness research and personal ... and exercise are highly beneficial and a rich ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Anitoa Systems, ... partnering with Zhejiang University of China, has successfully demonstrated ... ultra-low-light CMOS bio-optical sensor. Anitoa’s handheld qPCR is ... pathogen DNA and RNA’s, including hepatitis B, C, and ... of 4 copies per sample and over 9 orders ...
(Date:5/6/2015)... TU-Automotive has opened press registration for TU-Automotive Detroit as ... the headlines of major publications world-wide. With 150+ speakers ... ready to share their visions for the future of ... press to go behind the scenes and hear major ... “This year we’re releasing a preview of all the ...
(Date:5/6/2015)... WASHINGTON, DC (PRWEB) May 06, 2015 ... international organization representing the regenerative medicine and advanced ... first-ever quarterly data report, offering an in-depth look ... January through March 2015. , The report is ... standalone graphics highlighting key data points, available ...
Breaking Medicine News(10 mins):Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... The Environment and Health & Beauty Get a ... 3 HowToDoThings.com, a,popular online destination that helps ... instruction on diverse topics, celebrates the,world,s most popular ... coffee, in recognition of "Caffeine Awareness Month" in ...
... American Cancer Society, (http://www.cancer.org ) lists March 2008 ... the onset of colon cancer. According to the ... cases are discovered,annually...deaths from Colon and Rectal Cancer ... either avoid Colon Cancer or detect,tumors earlier than ...
... Scotland, March 3 Aircraft Medical, the UK,medical ... sponsoring the,prestigious 14th World Congress of Anaesthesiologists (the ... Draeger. Held every four,years, the WCA is the ... is Aircraft Medical sponsoring the event, but the ...
... same doctor during their first six months of life ... -- for lead poisoning, anemia and tuberculosis -- by ... by the same physician, often referred to as continuity ... children they studied. , Researchers from The Children,s Hospital ...
... Corporation of,North America, its U.S. subsidiary, MGI PHARMA, ... U.S. Food and Drug Administration,(FDA) has approved Aloxi(R) ... and vomiting (PONV) for up to 24 hours,following ... demonstrated., Aloxi, available in the United States ...
... cells may provide an explanation for the cause of ... causes premature aging in children, according to researchers at ... Institutes of Health (NIH). These findings, the first ... of HGPS, also known as progeria, may also provide ...
Cached Medicine News:Health News:HowToDoThings.com Brews Up New Uses for Coffee That Will Perk You Up in Recognition of March's 'Caffeine Awareness Month' 2Health News:SGV Medical Supplies: 'Colostomy Supplies Easier to Obtain for the Colon Cancer Survivor' 2Health News:Aircraft Medical to Sponsor World's Premier Anaesthesiology Conference 2Health News:In early childhood, continuous care by 1 doctor improves delivery of health screenings 2Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 2Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 3Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 4Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 5Health News:Adult stem cell changes underlie rare genetic disease associated with accelerated aging 2
... importance of electronic connectivity for ... understood. Transmission of patient results ... records, and billing. A sound ... connectivity is essential to ensure ...
248 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
... Discovery 90SE Ultracentrifuge offers ... discover more. All the ... top-of-the-line performance, powerful functionality, ... use, all built into ...
... g-force ever. But optimal productivity in the ... combines maximum force, capacity, and ease of ... apart from any other system. With advanced ... Optima takes productivity to the MAX. Optima ...
Medicine Products: